According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Foundation’s Vision Grant Program fund medical research pertaining to the pathophysiology, diagnosis, and treatment of hypertensive disorders of pregnancy.

The Preeclampsia Foundation, through the generous support of our donors, corporate partnerships, and community events such as The Promise Walk for Preeclampsia, has supported more than $550,000 in research since its founding in 2000. Successful projects have, in turn, garnered additional research support from major funding organizations, earned scientific merit at important meetings, and inspired young investigators to commit their life’s work to this complex field of study.

On February 13, 2019, the Preeclampsia Foundation announced at the Society for Maternal-Fetal Medicine’s (SMFM) 39th Annual Meeting that applications are now being accepted for its 2019 Vision Grant program. 

The Preeclampsia Foundation will award up to two medical research Vision Grants to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 USD each. The Foundation’s Canadian affiliate, Preeclampsia Foundation Canada, will also award one Vision Grant up to $20,000 CAD, to a Canadian researcher. 

Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows or Early Stage Investigators only are eligible to apply. Projects with the potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English.

Please note: The application period is closed and we are not currently accepting applications.